PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Deanol Aceglumate→

Deanol Aceglumate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
3342-61-8
Molecular formula
C11H22N2O6
Molecular weight
278.3 g/mol
Drug class
CNS stimulant and cholinergic precursor saltdeanol–N-acetyl-L-glutamate
Mechanism of action
A salt of deanol (2-dimethylaminoethanol) and N-acetyl-L-glutamate. Deanol is a choline-related precursor that has been proposed to influence acetylcholine availability and central cholinergic signalling; the pharmacological contribution of the aceglumate countercomponent and clinical mechanism are not well established.
Indications / reported uses
  • Marketed in some countries for cognitive symptoms or neurological complaints, but clinical efficacy evidence and authorised indications are limited and jurisdiction-specific. It should not be presented as an established treatment for dementia or other neurodegenerative disease.

Sources: https://precision.fda.gov/ginas/app/ui/substances/5fc41def-20e2-46ce-86d8-406a806a1691 · https://pubchem.ncbi.nlm.nih.gov/compound/71125 · https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL3833347 · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Deanol Aceglumate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Deanol Aceglumate Permitted Daily Exposure (PDE) report (the Deanol Aceglumate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Deanol Aceglumate Occupational Exposure Limit (OEL) report (the Deanol Aceglumate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.